Neurofilament levels in late preterm newborns
Part of Women’s health & pregnancy clinical trials.
This study looks at a substance in the blood called neurofilaments, which may help doctors understand early brain development in babies born a few weeks early. If your baby already needs a blood test, researchers will use a small extra sample to learn more.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born between 34 and 37 weeks of pregnancy.
- Your baby already needs a blood test for another medical reason.
- You, as a parent, can give signed permission for the study.
- Your baby does not have any known brain or nerve disorders.
- Your baby does not have serious birth defects.
- There is no medical reason preventing a blood draw.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects health information and biological samples from very premature babies to understand what affects their development. It may help researchers find ways to improve care and outcomes for infants like yours.
This trial tests whether measuring two pregnancy blood markers (sFlt1 and PlGF) and planning delivery timing can help prevent preeclampsia as you reach term. It may help reduce risk for mother and baby by guiding when to deliver based on test results.
This study looks at the fluid around your baby (amniotic fluid) and how it might affect your baby's gut health if they are born early. It may help doctors understand how to better care for preterm infants.
This study collects blood samples and health information from healthy full-term newborns to establish normal ranges for brain-related markers in early life. Understanding these baseline levels may help doctors better identify babies who need extra care in the future.
This study looks at two substances in the blood from the umbilical cord (IL-6 and lactate) to see if they can help doctors understand how well a newborn is doing after birth.
This pilot study looks at tiny particles in blood (microvesicles) to learn how they differ in women with threatened preterm delivery, with or without pre-eclampsia. Results may help doctors better identify risk and improve care for early delivery.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.